Richard Schwartz

Richard Schwartz



Richard Schwartz is an associate in the Antitrust practice group at Berger Montague.  Mr. Schwartz concentrates his practice in the area of complex antitrust litigation with a focus on representation of direct purchasers of prescription drugs.

Prior to joining Berger Montague, Mr. Schwartz was an attorney in the New York and Philadelphia offices of a firm where he represented plaintiffs in a variety of matters before trial and appellate courts with a focus on antitrust and shareholder class actions.

At Berger Montague, Mr. Schwartz is a member of the teams prosecuting a number of antitrust class actions on behalf of direct purchasers of prescription drugs in which the purchasers allege that generic drugs have been illegally kept off the market.  Those cases include In re Opana ER Antitrust Litigation, No. 14-cv-10151 (N.D. Ill.); In re Suboxone, No. 13-MD-2445 (E.D. Pa.); In re Solodyn, No. 14-MD-2503 (D. Mass.) and In re Celebrex, No. 14-cv-00361 (E.D. Va.).

Mr. Schwartz is admitted to practice in New York, Pennsylvania and Illinois.



Law School

University of Chicago Law School, J.D., 2004


University of Washington, B.A., 1997


Member – New York Bar

Member – Pennsylvania Bar

Member – Illinois Bar

Admitted – Southern District of New York

Admitted – Eastern District of New York

Admitted – Northern District of New York

Admitted – Eastern District of Pennsylvania

Admitted – Northern District of Illinois

Admitted – Second Circuit Court of Appeals

Admitted – Third Circuit Court of Appeals

Request A Free Consultation

  • This field is for validation purposes and should be left unchanged.